WealthTrak Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-59
Closed -$46K 542
2025
Q2
$46K Buy
59
+17
+40% +$13.2K 0.04% 111
2025
Q1
$34.7K Buy
42
+17
+68% +$14.1K 0.03% 118
2024
Q4
$19.3K Buy
+25
New +$20.7K 0.02% 133

Other funds holding LLY

WealthTrak Capital Management's LLY Position: Q3 2025 in Review

WealthTrak Capital Management sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 59 shares — an estimated $46K sold.

WealthTrak Capital Management first reported a position in LLY in Q4 2024 and held it in 3 quarters. The position peaked at $46K in Q2 2025. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • WealthTrak Capital Management reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • WealthTrak Capital Management sold 59 Eli Lilly shares in Q3 2025, an estimated $46K.
  • WealthTrak Capital Management first reported a position in Eli Lilly in Q4 2024 and held it in 3 quarters.
  • WealthTrak Capital Management's Eli Lilly position peaked at $46K in Q2 2025.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on WealthTrak Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.